BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3266555)

  • 1. Inactivation of serine proteinase inhibitors (serpins) in human plasma by reactive oxidants.
    Stief TW; Heimburger N
    Biol Chem Hoppe Seyler; 1988 Dec; 369(12):1337-42. PubMed ID: 3266555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative inactivation of purified human alpha-2-antiplasmin, antithrombin III, and C1-inhibitor.
    Stief TW; Aab A; Heimburger N
    Thromb Res; 1988 Mar; 49(6):581-9. PubMed ID: 2455361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reaction of human skin chymotrypsin-like proteinase chymase with plasma proteinase inhibitors.
    Schechter NM; Sprows JL; Schoenberger OL; Lazarus GS; Cooperman BS; Rubin H
    J Biol Chem; 1989 Dec; 264(35):21308-15. PubMed ID: 2592376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil oxidants inactivate alpha-1-protease inhibitor and promote PMN-mediated detachment of cultured endothelium. Protection by free methionine.
    Stroncek DF; Vercellotti GM; Huh PW; Jacob HS
    Arteriosclerosis; 1986; 6(3):332-40. PubMed ID: 3486653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis.
    Goldstein W; Döring G
    Am Rev Respir Dis; 1986 Jul; 134(1):49-56. PubMed ID: 2425673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different selectivities of oxidants during oxidation of methionine residues in the alpha-1-proteinase inhibitor.
    Maier KL; Matejkova E; Hinze H; Leuschel L; Weber H; Beck-Speier I
    FEBS Lett; 1989 Jul; 250(2):221-6. PubMed ID: 2546797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
    Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
    Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ozone and nitrogen dioxide on human lung proteinase inhibitors.
    Johnson DA
    Res Rep Health Eff Inst; 1987; (11):5-25. PubMed ID: 3268287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of inter-alpha-trypsin inhibitor and other proteinase inhibitors in the plasma clearance of neutrophil elastase and plasmin.
    Pratt CW; Roche PA; Pizzo SV
    Arch Biochem Biophys; 1987 Nov; 258(2):591-9. PubMed ID: 2445291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative inactivation of plasmin and other serine proteases by copper and ascorbate.
    Lind SE; McDonagh JR; Smith CJ
    Blood; 1993 Sep; 82(5):1522-31. PubMed ID: 8364203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin modulation of the fibrinolytic activity of plasmin, miniplasmin and neutrophil leukocyte elastase in the presence of plasma protease inhibitors.
    Kolev K; Komorowicz E; Machovich R
    Blood Coagul Fibrinolysis; 1994 Dec; 5(6):905-11. PubMed ID: 7534486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic enzymes and catabolism: enhanced release of granulocyte proteinases in uremic intoxication and during hemodialysis.
    Heidland A; Hörl WH; Heller N; Heine H; Neumann S; Heidbreder E
    Kidney Int Suppl; 1983 Dec; 16():S27-36. PubMed ID: 6376917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil-mediated solubilization of the subendothelial matrix: oxidative and nonoxidative mechanisms of proteolysis used by normal and chronic granulomatous disease phagocytes.
    Weiss SJ; Curnutte JT; Regiani S
    J Immunol; 1986 Jan; 136(2):636-41. PubMed ID: 3484496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elastase regulates the synthesis of its inhibitor, alpha 1-proteinase inhibitor, and exaggerates the defect in homozygous PiZZ alpha 1 PI deficiency.
    Perlmutter DH; Travis J; Punsal PI
    J Clin Invest; 1988 Jun; 81(6):1774-80. PubMed ID: 3260245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ozone effects on alpha-1-proteinase inhibitor in vivo: blood plasma inhibitory activity is unchanged.
    Johnson DA; Winters RS; Woolley T; Graham D; Henderson FW
    Exp Lung Res; 1986; 11(2):95-103. PubMed ID: 3489611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential mediator of inflammation. Phagocyte-derived oxidants suppress the elastase-inhibitory capacity of alpha 1-proteinase inhibitor in vitro.
    Carp H; Janoff A
    J Clin Invest; 1980 Nov; 66(5):987-95. PubMed ID: 6253528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Singlet oxygen ((1)O2) inactivates plasmatic free and complexed alpha2-macroglobulin.
    Stief TW; Kropf J; Kretschmer V; Doss MO; Fareed J
    Thromb Res; 2000 Jun; 98(6):541-7. PubMed ID: 10899353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of plasma proteinase inhibitors and the secretory leucocyte proteinase inhibitor on pancreatic elastase-induced degradation of some plasma proteins.
    Håkansson HO; Ohlsson K
    Gastroenterol Jpn; 1992 Oct; 27(5):652-6. PubMed ID: 1358738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative regulation of neutrophil elastase-alpha-1-proteinase inhibitor interactions.
    Ossanna PJ; Test ST; Matheson NR; Regiani S; Weiss SJ
    J Clin Invest; 1986 Jun; 77(6):1939-51. PubMed ID: 3519684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ozone inactivation of human alpha 1-proteinase inhibitor.
    Johnson DA
    Am Rev Respir Dis; 1980 Jun; 121(6):1031-8. PubMed ID: 6903114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.